Accropeutics Secured $12 Million in Series B Plus Financing
- Written by PR Newswire
- Approximately $12 million additional financing led by Shenzhen Capital Group (SCGC), with participation from existing investor Morningside Ventures, and new investors Leader Venture Investment (SZTI) and Hefei Sci-Tec Venture Capital (HFST).
- Cash runway extended into the second half of 2026
NEW YORK and SUZHOU, China, March 14, 2025 /PRNewswire/ --...













